Kyle Lefkoff, Director at ARRAY BIOPHARMA INC (ARRY), sold 50,000 shares at $17.45 ($873K) on 2018-07-06, disclosed to the SEC on 2018-07-06.
Open-market sale of $872k ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |
| MGEN | SELL | 2017-03-13 | $83K | — | Filing → |